Advertisement

Usefulness of Bedside Testing for Brain Natriuretic Peptide to Identify Right Ventricular Dysfunction and Outcome in Normotensive Patients With Acute Pulmonary Embolism

      Echocardiographic right ventricular (RV) dysfunction is a well-established prognostic indicator in patients with acute pulmonary embolism. However, the possibility of implementing a rapid and effective triage with biohumoral markers such as brain natriuretic peptide (BNP) may be of value. Sixty-one patients with a first documented episode of acute pulmonary embolism without shock and previous left ventricular dysfunction were prospectively studied. All patients underwent echocardiography and rapid BNP testing on admission. Patients were followed up for in-hospital death, progression to shock, and nonfatal pulmonary embolism recurrence. Overall, 35 patients (57%) had echocardiographic evidence of RV dysfunction on admission, and its prevalence increased progressively with increasing levels of BNP. A BNP level <85 pg/ml was highly accurate in excluding RV dysfunction. No patient in the lower tertile of BNP values (1.1 to 85.0 pg/ml) had RV dysfunction, compared with 75% in the middle tertile (88.7 to 487.0 pg/ml) and 100% in the upper tertile (527 to 1,300 pg/ml). Overall, 11 patients (18%), belonging to the upper tertile, progressed to shock during admission, 4 of whom died. The association of RV dysfunction with a BNP level in the upper tertile (≥527 pg/ml) showed incremental prognostic value over RV dysfunction alone (in-hospital death and progression to shock were 55% and 31%, respectively). In the present study, BNP represented a powerful predictor of in-hospital clinical deterioration, with substantial incremental prognostic value over echocardiography alone.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dao Q.
        • Krishnaswamy P.
        • Kazanegra R.
        • Harrison A.
        • Amirnovin R.
        • Lenert L.
        • Clopton P.
        • Alberto J.
        • Hlavin P.
        • Maisel A.S.
        Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting.
        J Am Coll Cardiol. 2001; 37: 379-385
        • Cheng V.L.
        • Krishnaswamy P.
        • Kazanegra R.
        • Garcia A.
        • Gardetto N.
        • Maisel A.S.
        A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure.
        J Am Coll Cardiol. 2001; 37: 386-391
        • Maisel A.S.
        • Koon J.
        • Krishnaswamy P.
        • Kazenegra R.
        • Clopton P.
        • Gardetto N.
        • Morrisey R.
        • Garcia A.
        • Chiu A.
        • De Maria A.
        Utility of B-natriuretic peptide (BNP) as a rapid, point-of-care test for screening patients undergoing echocardiography for left ventricular dysfunction.
        Am Heart J. 2001; 141: 367-374
        • Maisel A.S.
        • Krishnaswamy P.
        • Nowak R.M.
        • McCord J.
        • Hollander J.E.
        • Duc P.
        • Omland T.
        • Storrow A.B.
        • Abraham W.T.
        • Wu A.H.
        • et al.
        • Breathing Not Properly Study Investigators
        Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
        N Eng J Med. 2002; 347: 161-167
        • Teigen C.L.
        • Maus T.P.
        • Sheedy II, P.F.
        • Johnson C.M.
        • Stanson A.W.
        • Welch T.J.
        Pulmonary embolism.
        Radiology. 1993; 188: 839-845
        • Grifoni S.
        • Olivotto I.
        • Cecchini P.
        • Pieralli F.
        • Camaiti A.
        • Santoro G.
        • Conti A.
        • Agnelli G.
        • Berni G.
        Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction.
        Circulation. 2000; 101: 2817-2822
        • Kucher N.
        • Printzen G.
        • Doernhoefer T.
        • Windecker S.
        • Meier B.
        • Hess O.M.
        Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism.
        Circulation. 2003; 107: 1576-1578
        • Kucher N.
        • Printzen G.
        • Goldhaber S.Z.
        Prognostic role of brain natriuretic peptide in acute pulmonary embolism.
        Circulation. 2003; 107: 2545-2547
        • ten Wolde M.
        • Tulevski I.I.
        • Mulder J.W.
        • Sohne M.
        • Boomsma F.
        • Mulder B.J.
        • Buller H.R.
        Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism.
        Circulation. 2003; 107: 2082-2084
        • Kruger S.
        • Graf J.
        • Merx M.W.
        • Koch K.C.
        • Kunz D.
        • Hanrath P.
        • Janssens U.
        Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism.
        Am Heart J. 2004; 147: 60-65